Saphetor caught up with Constantia Aristidou from The Cyprus Institute of Neurology & Genetics (CING), that highlighted the breadth and scope of VarSome Clinical in their recently published paper; Exploring the Genetic Causality of Discordant...
Community VarSome.com VarSome Clinical VarSome in Action
0
When we ask people what they value most about VarSome, the most common response is “the classifiers”. In building our germline and somatic variant classifiers, we automated a very time-consuming and labor-intensive process. We apply the relevant...
VarSome.com VarSome Clinical VarSome.com Premium VarSome Team
Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...
We get a lot of great feedback on our classification tools. In particular, our germline classifier is a tool that healthcare professionals around the world constantly rely on to help them solve cases. This is because it implements recognized...
Technology VarSome API VarSome.com VarSome Clinical VarSome.com Premium ACMG
Saphetor is exhibiting at this year's European Society of Human Genetics conference in Glasgow, Scotland.
Aceragen, a biopharmaceutical company specializing in the development of treatments for rare genetic conditions, recently shared their novel approach to mapping Farber disease prevalence at ASHG 2022. Using VarSome Insights, the team were able to...
Saphetor Sa, A Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Maarten Kempen as Chief Commercial Officer, effective February 1st, 2023. Kempen will be responsible...
Our Head of Regulatory Affairs and Quality Assurance, Amélie Martinez, was featured in Inside Precision Medicine in an interview covering the upcoming impact and practical considerations labs are facing regarding IVDR.
Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision...
Press Releases Partnerships News
VarSome is exhibiting at this year's ASHG annual meeting in Los Angeles.
Conferences Partnerships Events News
RIYADH, Kingdom of Saudi Arabia--(BUSINESS WIRE)--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics...
Press Releases Partnerships News
Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...
Press Releases Partnerships News